(Mary Ann Liebert, Inc./Genetic Engineering News) A comprehensive new review of the expanding scope of stimulants available to treat attention deficit hyperactivity disorder (ADHD) serves as a valuable guide to clinicians as they choose from among the many new drug formulations and technologies available to treat this complex disorder. The wide-ranging review is published in the Journal of Child and Adolescent Psychopharmacology, a peer-reviewed journal from Mary Ann Liebert Inc. publishers.
from EurekAlert! - Social and Behavioral Science http://bit.ly/2wgZzbf
No comments:
Post a Comment